Availability of a translated consent document at study opening increases trial enrolment of patients who speak that language

Having a consent document translated into a patient's primary language available at the time of study opening increases that patient's likelihood of enrolling in the trial. The effect is language-specific: it raises enrolment of speakers of the language actually translated, not of non-English-speaking patients in general.